That the expression of SLC16A1 (MCT1 gene) mRNA is more consistent across DLBCL cell lines than SLC16A3 (Supplementary Fig. S1a), is in accordance with MCT1 and MCT4 protein levels in DLBCL patient samples [12]. This evidence concerns the gene SLC16A3 and diffuse large B-cell lymphoma.